During the past decade, Bronson Battle Creek conducted 149 clinical trials. In the 10-year time frame, 149 clinical trials started and 107 clinical trials were completed, i.e. on average, 71.8% percent of trials that started reached the finish line to date. In the past 5 years, 64 clinical trials started and 62 clinical trials were completed. i.e. 96.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bronson Battle Creek" #1 sponsor was "National Cancer Institute (NCI)" with 123 trials, followed by "SWOG Cancer Research Network" with 39 trials sponsored, "Alliance for Clinical Trials in Oncology" with 30 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 21 trials sponsored and "Gynecologic Oncology Group" with 21 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bronson Battle Creek" #1 collaborator was "National Cancer Institute (NCI)" with 130 trials as a collaborator, "NRG Oncology" with 21 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "NCIC Clinical Trials Group" with 6 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Bronson Battle Creek" are "Recurrent Breast Carcinoma" (10 trials), "Invasive Breast Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Breast Cancer AJCC v6 and v7" (9 trials) and "Stage IV Lung Cancer AJCC v8" (9 trials). Many other conditions were trialed in "Bronson Battle Creek" in a lesser frequency.

Most popular intervention types in "Bronson Battle Creek" are "Drug" (208 trials), "Other" (162 trials), "Biological" (95 trials), "Procedure" (65 trials) and "Radiation" (36 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (83 trials), "Quality-of-Life Assessment" (69 trials), "Questionnaire Administration" (48 trials), "Paclitaxel" (32 trials) and "Computed Tomography" (30 trials). Other intervention names were less common.

The vast majority of trials in "Bronson Battle Creek" are 194 trials for "All" genders, 53 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Bronson Battle Creek". undefined are not yet recruiting, 66 are recruiting, 104 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 67 completed trials in Bronson Battle Creek, 5 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Bronson Battle Creek, 7 "Phase 1" clinical trials were conducted, 122 "Phase 2" clinical trials and 129 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".